Medical Cannabis: What Do We Know & What Do We Not?

The Medical Cannabis Symposium is designed for healthcare professionals interested in learning about recent developments in the use of medical cannabis and medical cannabis research; challenges related to impairment, labeling, and synthetic cannabinoids; and legal and regulatory developments in PA.

Todd Herremans will close the Symposium discussing Medical Cannabis for Pain Management in Sports Medicine.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Friday, November 28, 2025. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Recognize unique clinical challenges that face clinicians who recommend medical cannabis for pain.
2. Review recommended starting dosage and route of delivery for a medical cannabis patient.
3. Evaluate the current therapeutic potential and risks of medical cannabis.
4. Identify the different types of cannabis products and method to record in electronic health records.
5. Reflect on current issues in state public policy and law from an unbiased educational discussion how laws shape the state's professional licensing board regulations, healthcare delivery, and medical practice.
6. Analyze the open exchange of ideas between the presenters, the faculty, state legislators, and the participants in the regulatory practice related to medical cannabis.
7. Critique the challenges of identifying cannabis impairment.
8. Differentiate semi-synthetic cannabinoids and those from naturally occurring cannabinoids.
9. Describe the current regulatory gaps that permit widespread sale of intoxicating hemp-derived products.
10. Identify key policy strategies for regulating semi-synthetic cannabinoids to safeguard public health.
11. Describe the major components of a properly labeled retail cannabis product.
12. Recognize the International Intoxicating Cannabinoid Product Symbol (IICPS) and its characteristics in comparison with other cannabis product symbols.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 2.50 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals: This educational activity is designated for 2.50 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Agenda
Agenda subject to change without notice.

Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Bluemle Life Sciences Building
Thomas Jefferson University
233 S. 10th Street
Philadelphia, PA 19107

Directions

Parking

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ruth Charbonneau, JD, RN
Program Director
The Lambert Center for the Study of Medicinal Cannabis and Hemp
Philadelphia, PA

Activity/Course Director, Faculty

Nothing to disclose

Ari Greis, DO
Rothman Institute
Philadelphia, PA

Co-Director, Faculty

Nothing to disclose

Monica Medina-McCurdy, PhD, PA-C
Assistant Professor
Thomas Jefferson University
Voorhees, NJ

Content Reviewer

Nothing to disclose

Asif Ilyas, MD, MBA
Rothman Opioid Foundation
Bryn Mawr, PA

Content Reviewer, Faculty

Nothing to disclose

Bryon Adinoff, MD, DFAPA, FAAAP
Clinical Professor
University of Colorado Anschutz Medical Campus
Denver, CO

Faculty

Advisor-DemeRx Inc

Marcel O Bonn-Miller, PHD
Chief Scientific Officer
Charlotte's Web
Sarasota, FL

Faculty

Employment-Charlotte's Web|Stocks or stock options, excluding diversified mutual funds-Charlotte's Web|Stocks or stock options, excluding diversified mutual funds-DeFloria |Stocks or stock options, excluding diversified mutual funds-Ajna Bio

Amanda M Cappelletti, Other
PA State Senator-Senate District 7
PA State Senate
Harrisburg, PA

Faculty

Non-Clinical Exception

Todd Herremans
Philadelphia, PA

Faculty

Non-Clinical Exception

Tarkik Khan, Other
PA State Representative-194th District, Philadelphia County
PA House of Representatives
Harrisburg, PA

Faculty

Non-Clinical Exception

Jahan Marcu, PhD
CEO
Delaware Analytical, LLC
Jersey City, NJ

Faculty

Nothing to disclose

David L. Nathan, MD, DLFAPA
Co-founder and Past President
Doctors for Drug Policy Reform (D4DPR)
Princeton, NJ

Faculty

Nothing to disclose

Christopher M Rabb, Other
PA Representative-200th District Philadelphia County
PA House of Representatives
Harrisburg, PA

Faculty

Non-Clinical Exception

Ryan G Vandrey, PHD
Professor
Johns Hopkins University
Forest Hill, NJ

Faculty

Advisor-Charlotte's Web|Advisor-Syqe Medical Ltd

Eugene Vortsman, DO
Northwell Health
New Hyde Park, NY

Faculty

Saturday, November 8, 2025

This educational activity received no commercial or in-kind support.